Document:

<PAGE>

                                                                   EXHIBIT 10.10
                                                                   -------------

                          REGISTRATION RIGHTS AGREEMENT

                                 January 4, 2002

     The parties to this agreement are MedSource Technologies, Inc., a Delaware
corporation (the "Company"), and each of the other individuals or entities
executing a signature page to this agreement (collectively, the "Stockholders").

     Simultaneously with the execution and delivery of this agreement, the
Stockholders are acquiring shares of the Company's common stock, par value $.01
per share ("Common Stock"), pursuant to an Agreement and Plan of Merger dated as
of December 31, 2001 among the Company, MedSource Trenton, Inc., HV
Technologies, Inc. ("HV") and Rudolph E. Carlson, as the representative of HV's
shareholders. Such shares of Common Stock are the only shares of capital stock
of the Company entitled to the rights and benefits, and subject to the terms and
conditions, of this agreement, and are hereinafter collectively referred to as,
the "Shares."

     The Company desires to provide to the Stockholders certain rights regarding
the registration of the Shares, all upon the terms and conditions set forth
below.

     It is therefore agreed as follows:

     1.  Certain Definitions. As used in this agreement, the following terms
shall have the meanings provided below:

         (a)  "Commission" means the United States Securities and Exchange
Commission or any other federal agency at the time administering the Securities
Act.

         (b)  "Holders" means the Stockholders and their respective permitted
transferees who hold Shares.

         (c)  "Other Securities" means, at any time, those shares of Common
Stock, and of any other class or series of capital stock of the Company or other
securities of the Company representing the right to acquire Common Stock, that
the Company is required to, or has determined to, register pursuant to a
registration statement filed by the Company with the Commission pursuant to this
or any other agreement.

         (d)  "Person" shall mean any individual, partnership, joint venture,
firm, corporation, association, trust or other enterprise or any government or
political subdivision or any agency, department or instrumentality thereof.

         (e)  "Registrable Securities" means the Shares and any other securities
issuable in replacement thereof by way of a recapitalization, exchange, merger,
consolidation, reorganization or other transaction; provided, however, that any
share shall cease to be a Registrable Security under this agreement when (A) a
registration statement with respect to such share's public sale shall have
become effective under the Securities Act, (B) it has been disposed of as
permitted by, and in compliance with, Rule 144 (or successor provision)
promulgated under the Securities Act or (C) it shall have ceased to be
outstanding.

<PAGE>

         (f)  "Registration Expenses" means all expenses incident to the
Company's performance of or compliance with the provisions of section 2
including, without limitation, all registration, filing and National Association
of Securities Dealers, Inc. fees, all listing fees, all fees and expenses of
complying with securities or blue sky laws (including, without limitation,
reasonable fees and disbursements of counsel for the underwriters in connection
with blue sky qualifications of the Registrable Securities hereunder), all word
processing, duplicating and printing expenses, messenger and delivery expenses,
the fees and disbursements of counsel for the Company, and the reasonable fees
and expenses of one counsel on behalf of the Stockholders (including the
Holders) whose shares of Common Stock are included in the registration
statement, with such counsel selected by a majority-in-interest of such holders
(according to the number of shares of Common Stock each such holder is directly
or indirectly registering for sale in such registration statement), and the fees
and disbursements of its independent public accountants, including the expenses
of "comfort" letters required by or incident to such performance and compliance,
and any fees and disbursements of underwriters customarily paid by issuers or
sellers of securities; provided, however, that Registration Expenses shall
exclude, and the Holders shall pay, underwriters fees and underwriting discounts
and commissions in respect of the Registrable Securities being registered
hereunder as well as any fees and expenses of counsel to the Holders of the
Registrable Securities hereunder (other than those of the one counsel referred
to above).

         (g)  "Securities Act" means the Securities Act of 1933, as amended, and
any subsequent similar federal statute, and the rules and regulations
promulgated thereunder.

     2.  Piggyback Registration.
         ----------------------

         2.1  Right to Include Registrable Securities.
              ---------------------------------------

         (a)  Subject to section 2.1(b), if the Company at any time proposes to
register any of its securities under the Securities Act (as defined below) by
registration on Forms SB-2, S-1, S-2, S-3 (but not Forms S-4 or S-8) or any
successor or similar form(s) (except registrations on such or similar forms for
registration of securities in connection with (i) an employee benefit plan or
dividend reinvestment plan or a merger, consolidation or other business
combination, (ii) debt securities that are not convertible into Common Stock, or
(iii) the Company's initial public offering), whether or not for sale for its
own account, it shall, each such time, give written notice to the Holders of its
intention to do so and of the Holders' rights under this section 2 at least 30
days prior to the filing of a registration statement with respect to such
registration with the Commission. Upon the written request of any Holder made
within 20 days after the receipt of that notice, which request shall specify the
Registrable Securities intended to be registered and disposed of by such Holder,
the Company shall, subject to the provisions hereof, use its commercially
reasonable efforts to include in such registration statement all Registrable
Securities that the Company has been so requested to register by such Holder.

         (b)  If, at any time after giving written notice of its intention to
register any securities and prior to the effective date of the registration
statement filed in connection with such registration, the Company shall
determine for any reason not to register or to delay registration of such
securities, the Company may, at its election, give written notice of such
determination to each Holder and upon giving that notice (i) in the case of a
determination not to register, the Company shall be relieved of its obligation
to register any Registrable Securities in connection with such registration (but
not from any obligation of the Company to pay the

                                       -2-

<PAGE>

Registration Expenses (as defined below) in connection therewith), without
prejudice; and (ii) in the case of a determination to delay registering, the
Company shall be permitted to delay registering any Registrable Securities for
the same period as the delay in registering such other securities.

         (c)  The Company shall pay all Registration Expenses in connection with
registration of Registrable Securities requested pursuant to this section 2.1.

         2.2  Underwriter "Cutbacks" in Piggyback Registrations. Anything in
              -------------------------------------------------
section 2.1 to the contrary notwithstanding, with respect to any registration
pursuant to which shares are registered pursuant to this section 2 that is being
effected by one or more underwriters, such underwriters shall be designated by
the Company and approved by a majority in interest of the Holders selling
Registrable Securities and Other Securities (which approval shall not be
unreasonably withheld), and if any managing underwriter for the public offering
contemplated by such registration advises the Company in writing that, in such
firm's good faith opinion, the inclusion of all Registrable Securities and Other
Securities proposed to be included in such registration would adversely affect
the offering and sale of all such securities, then all securities proposed to be
sold by the Company for its own account shall be included in such registration
to the extent possible and the number of Registrable Securities and Other
Securities proposed to be included in such registration shall be reduced pro
rata based upon the number of shares of Common Stock owned by each such Person
(other than the Company) and its affiliates (or that each such Person and its
affiliates have the right to acquire) at the time of such registration.

     3.  Registration Procedures. In connection with the registration of any
         -----------------------
Registrable Securities under the Securities Act as provided in section 2, the
Company shall as expeditiously as possible:

              (i)    prepare and file with the Commission the requisite
     registration statement to effect such registration and thereafter use its
     commercially reasonable efforts to cause such registration statement to
     become and remain effective (subject to clause (ii) below); provided,
     however, that the Company may discontinue any registration of its
     securities that are not Registrable Securities at any time prior to the
     effective date of the registration statement relating thereto;

              (ii)   prepare and file with the Commission such amendments and
     supplements to such registration statement and the prospectus used in
     connection therewith as may be necessary to keep such registration
     statement effective and to comply with the provisions of the Securities Act
     with respect to the disposition of all Registrable Securities covered by
     such registration statement for such period as shall be required for the
     disposition of all of such Registrable Securities; provided, however, that,
     the foregoing notwithstanding, the Company shall not be required under this
     item (ii) to maintain the effectiveness of any such registration statement
     for longer than 180 days, or such longer period beyond such 180 days (up to
     an aggregate of 270 days) as may be available without requiring the Company
     to file any financial statements as of a later date and for a later period
     than the financial statements that may have been required to maintain the
     effectiveness of the registration statement for the 180-day period;

              (iii)  furnish to the Holders such number of conformed copies
     of such registration statement and of each such amendment and supplement
     thereto (in each case

                                       -3-

<PAGE>

     including all exhibits), such number of copies of the prospectus contained
     in such registration statement (including each preliminary prospectus and
     any summary prospectus) and any other prospectus filed under Rule 424 under
     the Securities Act, in conformity with the requirements of the Securities
     Act, and such other documents, as the Holders may reasonably request from
     time to time;

              (iv)   use its commercially reasonable efforts (x) to register or
     qualify all Registrable Securities and other securities covered by such
     registration statement under such other securities or blue sky laws of such
     states of the United States of America where an exemption is not available
     and as the Holders shall reasonably request, (y) to keep such registration
     or qualification in effect for so long as such registration statement
     remains in effect, and (z) to take any other action that may reasonably be
     necessary or advisable to enable the Holders to consummate the disposition
     in such jurisdictions of the securities to be sold by the Holders, except
     that the Company shall not for any such purpose be required to qualify
     generally to do business as a foreign corporation in any jurisdiction
     wherein it would not, but for the requirements of this paragraph (iv), be
     obligated to be so qualified or to consent to general service of process in
     any such jurisdiction;

              (v)    use its commercially reasonable efforts to cause all
     Registrable Securities covered by such registration statement to be
     registered with or approved by such other federal or state governmental
     agencies or authorities as may be necessary in the opinion of counsel to
     the Company to consummate the disposition of such Registrable Securities in
     accordance with their intended method of disposition;

              (vi)   furnish to the Holders' underwriters, if any, (x) an
     opinion of counsel for the Company, and (y) a "comfort" letter signed by
     the independent public accountants who have certified the Company's
     financial statements included or incorporated by reference in such
     registration statement, each covering substantially the same matters with
     respect to such registration statement (and the prospectus included
     therein) and, in the case of the accountant's comfort letter, with respect
     to events subsequent to the date of such financial statements, as are
     customarily covered in opinions of issuer's counsel and in accountant's
     comfort letters delivered to the underwriters in underwritten public
     offerings of securities (and dated the dates such opinions and comfort
     letters are customarily dated);

              (vii)  immediately notify the Holders when a prospectus relating
     thereto is required to be delivered under the Securities Act, upon
     discovery that, or upon the happening of any event as a result of which,
     the prospectus included in such registration statement, as then in effect,
     includes an untrue statement of a material fact or omits to state any
     material fact required to be stated therein or necessary to make the
     statements therein not misleading, in the light of the circumstances under
     which they were made, and at the request of the Holders promptly prepare
     and furnish to them a reasonable number of copies of a supplement to or an
     amendment of such prospectus as may be necessary so that, as thereafter
     delivered to the purchasers of such securities, such prospectus shall not
     include an untrue statement of a material fact or omit to state a material
     fact required to be stated therein or necessary to make the statements
     therein not misleading in the light of the circumstances under which they
     were made;

                                       -4-

<PAGE>

              (viii)  otherwise use its commercially reasonable efforts to
     comply with all applicable rules and regulations of the Commission, and
     make available to its security holders, as soon as reasonably practicable,
     an earnings statement covering the period of at least 12 months, but not
     more than 18 months, beginning with the first full calendar month after the
     effective date of such registration statement, which earnings statement
     shall satisfy the provisions of section 11(a) of the Securities Act and
     Rule 158 promulgated thereunder, and promptly furnish the same to the
     Holders; and

              (ix)    provide and cause to be maintained a transfer agent and
     registrar (which, in each case, may be the Company) for all Registrable
     Securities covered by such registration statement from and after a date not
     later than the effective date of such registration.

         The Company may require the Holders to furnish the Company such
information regarding the Holders and the distribution of the Holders'
Registrable Securities as the Company may from time to time reasonably request
in writing, based on its reasonable belief that such information is required to
be disclosed in the Registration Statement pursuant to the Securities Act and
applicable State securities laws.

         Upon receipt of any notice from the Company of the happening of an
event of the kind described in item (vii) of this section 3, the Holders shall
forthwith discontinue their disposition of Registrable Securities pursuant to
the registration statement relating to such Registrable Securities until the
Holders' receipt of the copies of the supplemented or amended prospectus
contemplated by item (vii) and, if so directed by the Company, the Holders shall
deliver to the Company all copies, other than permanent file copies, then in the
Holders' possession, of the prospectus relating to such Registrable Securities
current at the time of receipt of such notice.

     4.  Underwritten Offerings.
         ----------------------

         4.1  Piggyback Underwritten Offerings. If the Company proposes to
              --------------------------------
register any of its securities under the Securities Act as contemplated by
section 2 and such securities are to be distributed by or through one or more
underwriters, the Company shall, subject to the provisions of section 2
(including, without limitation, the provisions of sections 2.2), if requested by
the Holders, arrange for such underwriters to include all the Registrable
Securities to be offered and sold by the Holders with and among the securities
of the Company to be distributed by such underwriters. The Holders shall become
a party to the underwriting agreement negotiated between the Company and such
underwriters and shall make all representations and warranties to and shall
enter into all agreements with the Company or the underwriters as shall be
reasonably requested of them including all representations and warranties
required by law, customarily given or reasonably requested of selling
shareholders by an underwriter in an underwritten public offering.

         4.2  Holdback Agreements.
              -------------------

         (a)  If the Company, in connection with an underwritten offering of
securities for its own account, at any time shall register shares of Common
Stock under the Securities Act for sale to the public (other than on Forms S-4
or S-8 or a shelf registration), the Holders shall not sell pursuant to an
effective registration statement, publicly make any short sale of, publicly

                                       -5-

<PAGE>

grant any option for the purchase of, or otherwise publicly dispose of any
Shares (other than those Shares included in such registration pursuant to
section 2) without the prior written consent of the managing underwriter for a
period required by the underwriters and designated by the Company, which period
shall begin not more than thirty (30) days prior to the effectiveness of the
registration statement pursuant to which such public offering shall be made and
shall last not more than one hundred eighty (180) days after the effective date
of such registration statement in the case of the Company's initial public
offering, or ninety (90) days after the effective date of such registration
statement in the case of any such other offering. The Company may legend and
impose stop transfer instructions on any certificate evidencing Registrable
Securities relating to the restrictions provided in this section 4.2.

         (b)  During the 15-day period prior to the effective date of any
registration statement of Registrable Securities pursuant to an underwritten
public offering and during the 90-day period beginning on that effective date,
the Company shall not (except as part of such registration) effect any public
sale or distribution of any of its equity securities or of any security
convertible into or exchangeable or exercisable for any equity security of the
Company (other than in connection with any employee stock option or other
benefit plan).

         4.3  Preparation; Reasonable Investigation. In connection with the
              -------------------------------------
preparation and filing of each registration statement under the Securities Act
pursuant to this agreement, the Company shall give the Holders, their
underwriters, if any, and their respective counsel and accountants the
opportunity to participate in the preparation of such registration statement,
each prospectus included therein or filed with the Commission, and each
amendment thereof or supplement thereto, and give each of them such access to
its books and records, such opportunities to discuss the business of the Company
with officers and the independent public accountants who have certified its
financial statements as shall be necessary, in the opinion of the Holders' and
such underwriters' respective counsel, to conduct a reasonable investigation
within the meaning of the Securities Act.

     5.  Indemnification.
         ---------------

         5.1  Indemnification by the Company. In the event of any registration
              ------------------------------
statement filed pursuant to section 2, the Company shall, and hereby does,
indemnify and hold harmless each of the Holders and each of their directors,
officers, partners, agents, attorneys, representatives and affiliates and each
other individual, group, partnership, corporation, business trust, joint stock
company, trust, unincorporated association, joint venture or other entity of
whatever nature ("Person") who participates as an underwriter in the offering or
sale of such securities and each other Person, if any, who controls any Holder
or any such underwriter within the meaning of the Securities Act (each of the
foregoing, a "Holder Indemnitee"), insofar as losses, claims, damages, or
liabilities (or actions or proceedings, whether commenced or threatened, in
respect thereof) arise out of or are based upon any untrue statement or alleged
untrue statement of any material fact contained in any such registration
statement, any preliminary prospectus, final prospectus, or summary prospectus
contained therein, or any amendment or supplement thereto, or any omission or
alleged omission to state therein a material fact required to be stated therein
or necessary to make the statements therein in light of the circumstances in
which they were made not misleading, and the Company shall reimburse each Holder
Indemnitee for any legal or any other fees, costs and expenses reasonably
incurred by them in connection with investigating or defending any such loss,
claim, liability, action or proceeding; provided, that the Company shall not be
liable in any such case to the extent that any

                                       -6-

<PAGE>

such loss, claim, damage, liability (or action or proceeding in respect thereof)
or expense arises out of or is based upon an untrue statement or omission made
in reliance upon and in conformity with information furnished to the Company by
or on behalf of a Holder or such underwriter, as the case may be, for use in the
preparation thereof; and provided, further, that the Company shall not be liable
to any Holder Indemnitee in any such case to the extent that any such loss,
claim, damage, liability (or action or proceeding in respect thereof) or expense
arises out of such Person's failure to send or give a copy of the final
prospectus, as the same may be then supplemented or amended, to the Person
asserting an untrue statement or alleged untrue statement or omission or alleged
omission at or prior to the written confirmation of the sale of Registrable
Securities to such Person if such statement or omission was corrected in such
final prospectus so long as such final prospectus, and any amendments or
supplements thereto, have been furnished to such underwriter or any Holder, as
applicable.

               5.2  Indemnification by the Holders. If any Registrable
                    ------------------------------
Securities are included in any registration statement, the Holders of such
Registrable Securities so registered shall, and hereby do, severally and not
jointly, indemnify and hold harmless (in the same manner and to the same extent
as set forth in section 5.1 above) the Company, and each director and officer of
the Company, and each other Person, if any, who controls the Company within the
meaning of the Securities Act, with respect to all losses, claims, damages,
expenses or liabilities ("Losses") to which the Company or such control person
becomes subject under the Securities Act, insofar as such Losses arise out of or
are based upon any untrue statement or alleged untrue statement of a material
fact contained in such registration statement, any preliminary prospectus, final
prospectus or summary prospectus contained therein, or any amendment or
supplement thereto, or an omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements
therein not misleading, if such statement or alleged statement or omission or
alleged omission was made in reliance upon and in conformity with written
information pertaining to such Holder and furnished to the Company by such
Holder for use in the preparation of such registration statement, preliminary
prospectus, final prospectus, summary prospectus, amendment or supplement,
provided, however, that no Holder shall have any liability under this section
6.2 for any amount in excess of the net proceeds actually received by such
Holder from the sale of the Registrable Securities included in such registration
statement.

               5.3  Notice of Claims, Etc.
                    ---------------------

               (a) Promptly after receipt by an indemnified party of notice of
the commencement of any action or proceeding involving a claim referred to in
sections 5.1 or 5.2, such indemnified party will, if a claim in respect thereof
is to be made against an indemnifying party, immediately give written notice to
the latter of the commencement of such action; provided, however, that the
failure of any indemnified party to give notice as provided herein shall not
relieve the indemnifying party of its indemnity obligations, except to the
extent that the indemnifying party is actually prejudiced by such failure to
give notice. In case any such action is brought against an indemnified party,
unless in the reasonable judgment of counsel for such indemnified party, a
conflict of interest between such indemnified and indemnifying parties may exist
in respect of such claim (in which case the indemnified party shall be entitled
to retain separate counsel as provided below), the indemnifying party shall be
entitled to participate in and to assume the defense thereof, jointly with any
other indemnifying party similarly notified to the extent that it may wish and
at any time, with counsel reasonably satisfactory to such indemnified party, and
after notice from the indemnifying party to such indemnified party of its
election so to

                                       -7-

<PAGE>

assume the defense thereof, the indemnifying party shall not be liable to
such indemnified party for any legal or other expenses subsequently incurred by
the indemnified party in connection with the defense thereof other than
reasonable costs related to the indemnified party's cooperation with the
indemnifying party provided, however, that (i) if the indemnifying party fails
to assume the defense of such claim after a reasonable time the indemnified
party may retain counsel to defend such claim and the reasonable fees and
expenses of such counsel shall be paid by the indemnifying party, (ii) the
indemnified party may, at its own expense, retain separate counsel to
participate in such defense, (iii) the indemnified party shall have the right to
employ separate counsel at the expense of the indemnifying party and to control
its own defense of such action, claim or proceeding if, in the reasonable
opinion of counsel to such indemnified party, a material conflict or potential
material conflict exists between the indemnified party and the indemnifying
party that would make such separate representation advisable, except that in no
event shall the indemnifying party be required to pay fees and expenses under
this section 6 for more than one separate firm of attorneys in any one legal
action or group of related legal actions.

               (b)  No indemnifying party shall be liable for any settlement of
any action or proceeding effected without its written consent, which consent
shall not be unreasonably withheld. No indemnifying party shall, without the
consent of the indemnified party, consent to entry of any judgment or enter into
any settlement that does not include as an unconditional term thereof the giving
by the claimant or plaintiff to such indemnified party of a release from all
liability in respect to such claim or litigation.

               5.4  Contribution. If indemnification shall for any reason be
                    ------------
held by a court to be unavailable to an indemnified party under section 5.1 or
section 5.2 in respect of any loss, claim, damage or liability, or any action in
respect thereof, then, in lieu of the amount paid or payable under section 5.1
or section 5.2, as applicable, the indemnified party and the indemnifying party
shall contribute to the aggregate losses, claims, damages and liabilities
(including legal or other expenses reasonably incurred in connection with
investigating the same), (i) in such proportion as is appropriate to reflect the
relative fault of the Company on the one hand and the Holders on the other hand
that resulted in such loss, claim, damage or liability, or action in respect
thereof, with respect to the statements or omissions that resulted in such loss,
claim, damage or liability, or action in respect thereof, as well as any other
relevant equitable considerations or (ii) if the allocation provided by item (i)
above is not permitted by applicable law, in such proportion as shall be
appropriate to reflect the relative benefits received by the Company on the one
hand and the Holders on the other provided, however, that no Holder shall have
any liability under this section 5.4 for any amount in excess of the net
proceeds actually received by such Holder from the sale of the Registrable
Securities included in such registration statement. No Person guilty of
fraudulent misrepresentation (within the meaning of the Securities Act) shall be
entitled to contribution from any Person who was not guilty of such

fraudulent misrepresentation. In addition, no Person shall be obligated to
contribute hereunder any amounts in payment for any settlement of any action or
claim, effected without such Person's consent, which consent shall not be
unreasonably withheld.

               5.5  Rule 144. With a view to making available the benefits of
                    --------
certain rules and regulations of the Commission that may at any time permit the
sale of the Registrable Securities to the public without registration, at all
times from and after 90 days following the effective date of the first
registration of the Company under the Securities Act of an offering of its
securities to the public, the Company shall:

                                       -8-

<PAGE>

               (a)  use its commercially reasonable efforts to facilitate the
sale of the Registrable Securities to the public, without registration under the
Securities Act, pursuant to Rule 144 promulgated under the Securities Act,
provided that this shall not require the Company to file reports under the
Securities Act and the Securities Exchange Act of 1934, or any similar federal
statute, and the rules and regulations of the Commission thereunder ("Exchange
Act"), at any time prior to the Company's being otherwise required to file such
reports;

               (b)  make and keep public information available, as those terms
are understood and defined in Rule 144 promulgated under the Securities Act at
all times after 90 days after the effective date of the first registration under
the Securities Act filed by the Company for an offering of its securities to the
general public;

               (c)  use its commercially reasonable efforts to then file with
the Commission in a timely manner all reports and other documents required of
the Company under the Securities Act and the Exchange Act; and

               (d)  deliver to the Holders, upon any Holder's request, a written
statement as to whe ther it has complied with the requirements of this section
5, a copy of the most recent annual or quarterly report of the Company filed
with the Commission or any stock exchange or self regulatory organization
registered under the Securities Exchange Act of 1934, and such other reports and
documents so filed as a Holder may reasonably request to avail itself of any
rule or regulation of the Commission allowing it to sell its Registrable
Securities without registration.

          6.   Representations and Warranties of the Company and the
               -----------------------------------------------------
Stockholder. The Company, on the one hand, and each of the Stockholders, on the
-----------
other hand, hereby represent and warrant to the other as set forth below (all of
such representations and warranties to survive the execution and delivery of
this agreement):

               (a)  Binding Effect. This agreement has been duly executed and
delivered by the Company or such Stockholder, as applicable, and constitutes the
legal, valid and binding obligation of such party enforceable against such party
in accordance with its terms, except as enforceability may be limited by
applicable bankruptcy, insolvency or other similar laws affecting the
enforcement of creditors' rights generally and by general principles of equity
relating to enforceability.

               (b)  Power; Authorization; Non-Contravention. Each of the Company
and such Stockholder, as applicable, has all power and authority to execute,
deliver and perform his, her or its obligations under this agreement. The
execution, delivery and performance by each of the Company or such Stockholder,
as applicable, of this agreement and the consummation of the transactions
contemplated hereby, (i) has been duly authorized by all necessary corporate or
limited liability company, and if required, stockholder action, as applicable,
on the part of or on behalf of such party and (ii) does not violate, contravene
the terms of, or exceed the authority grant under, any agreement, document or
instrument of or applicable to such party.

          7.   Miscellaneous.
               -------------

               (a)  Notices. All notices, instructions and other communications
                    -------
in connection with this agreement shall be in writing and may be given by (i)
fax (with evidence of receipt) followed by letter or other delivery, (ii)
personal delivery or (iii) by a nationally recognized

                                       -9-

<PAGE>

overnight courier in each case to the parties at the address of the Company as
follows, and at the address of the Stockholders as set forth on the signature
page to this agreement (or at such other address as the Company or the
Stockholders may specify):

               If to the Company:

               MedSource Technologies, Inc.
               110 Cheshire Lane, Suite 100
               Minneapolis, Minnesota 55447
               Telecopier No.: (612) 807-1235
               Attention: Chairman

               With a copy to:

               Jenkens & Gilchrist Parker Chapin LLP
               The Chrysler Building
               405 Lexington Avenue
               New York, New York  10174
               Telecopier No.: (212) 704-6288
               Attention: Edward R. Mandell

               If to a Stockholder, to the address of such Stockholder set forth
on a signature page below.

               (b)  No Waiver. No course of dealing and no delay on the part of
                    ---------
any party hereto in exercising any right, power or remedy conferred by this
agreement shall operate as a waiver thereof or otherwise prejudice such party's
rights, powers and remedies conferred by this agreement or shall preclude any
other or further exercise thereof or the exercise of any other right, power and
remedy.

               (c)  Binding Effect; Assignability. This agreement shall be
                    -----------------------------
binding upon and, except as otherwise provided herein, shall inure to the
benefit of the respective parties and their permitted successors and assigns.

               (d)  Severability. Any provision of this agreement that is
                    ------------
prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction,
be ineffective to the extent of such prohibition or unenforceability without
invalidating the remaining provisions hereof, and any such prohibition or
unenforceability in any jurisdiction shall not invalidate or render
unenforceable such provision in any other jurisdiction. To the extent permitted
by applicable law, the parties hereby waive any provision of law which renders
any provisions hereof prohibited or unenforceable in any respect.

               (e)  Modification. No term or provision of this agreement may be
                    ------------
amended, altered, modified, rescinded or terminated except upon the express
written consent of the party against whom the same is sought to be enforced.

               (f)  Law Governing. This agreement shall be governed by and
                    -------------
construed in accordance with the law of the state of Delaware, applicable to
agreements made and to be performed entirely in Delaware, without regard to the
principals of conflicts of law of such state.

                                       -10-

<PAGE>

               (g)  Amendment to Securities Laws. The Company (on the one hand)
                    ----------------------------
and the Stockholders (on the other hand) agree that any amendment to federal
securities laws (and regulations promulgated thereunder (and related
registration forms) and related state securities laws) shall not affect the
substantive registration requirements (and other obligations of the Company) set
forth in this agreement; and, following any such amendment, the Company shall
continue to be required to cause the registration of the Registrable Securities
(and pay all Registration Expenses and provide indemnification pursuant to
section 5.1) under the federal securities laws, as amended, in a manner
consistent with carrying out the intent and purposes of (and on terms as similar
as practicable as the terms set forth in) this agreement.

               (h)  Headings. All headings and captions in this agreement are
                    --------
for purposes of reference only and shall not be construed to limit or affect the
substance of this agreement.

               (i)  Entire Agreement. This agreement contains, and is intended
                    ----------------
as, a complete statement of all the terms of the arrangements between the
parties with respect to the matters provided for, supersedes any previous
agreements and understandings between the parties with respect to those matters
and cannot be changed or terminated orally.

                      [The next page is the signature page]

                                       -11-

<PAGE>

          The parties have executed and delivered this Registration Rights
Agreement as of the date first written above.

                                  MEDSOURCE TECHNOLOGIES, INC.

                                  By: /s/ DANIEL CROTEAU
                                      ------------------------------------------
                                  Name: Daniel Croteau
                                  Title: Vice President - Corporate Development

                 [Stockholder signatures begin on the next page]

                                       -12-

<PAGE>

                                   /s/
                                   --------------------------------------------
                                            Name: Richard Gerrish

                                   Address:

                                   7 Paddock Circle
                                   Tequesta, FL 33469
                                   Telecopier No.: (561) 746-0238

                                   /s/
                                   --------------------------------------------
                                            Name: Meredith Gerrish

                                   Address:

                                   7 Paddock Circle
                                   Tequesta, FL 33469
                                   Telecopier No.: (561) 746-0238

                                      S-2

         [MedSource Technologies, Inc. - Registration Rights Agreement
                         - Stockholder Signature Page]

<PAGE>

                                   /s/
                                   --------------------------------------------
                                            Name: Rodney Peifer

                                   Address:

                                   7073 Buttercup Lane
                                   Doltewah, TN 37363
                                   Telecopier No.: (423) 344-2268

                                      S-2

         [MedSource Technologies, Inc. - Registration Rights Agreement
                         - Stockholder Signature Page]

<PAGE>

                                   /s/
                                   --------------------------------------------
                                            Name: Bruce A. Nichols

                                   Address:

                                   9314 Ancient Oaks Drive
                                   Doltewah, TN 37363
                                   Telecopier No.: (423) 899-9220

                                      S-2

         [MedSource Technologies, Inc. - Registration Rights Agreement
                         - Stockholder Signature Page]

<PAGE>

                                   /s/
                                   --------------------------------------------
                                            Name: Stanley L. Porter

                                   Address:

                                   1679 Co. Rd. 147
                                   Henagar, AL 35978
                                   Telecopier No.: (256) 657-5340

                                      S-2

         [MedSource Technologies, Inc. - Registration Rights Agreement
                         - Stockholder Signature Page]

<PAGE>

                                   /s/
                                   --------------------------------------------
                                            Name: Jiles L. Dean, Jr.

                                   Address:

                                   852 Cave Springs Road
                                   Rising Fawn, GA 30738
                                   Telecopier No.: (706) 462-2618

                                      S-2

         [MedSource Technologies, Inc. - Registration Rights Agreement
                         - Stockholder Signature Page]

<PAGE>

                                   /s/
                                   --------------------------------------------
                                            Name: Jay W. Brown

                                   Address:

                                   38 Autumn Drive
                                   Ringgold, GA 30736
                                   Telecopier No.: (706) 935-5531

                                      S-2

         [MedSource Technologies, Inc. - Registration Rights Agreement
                         - Stockholder Signature Page]

<PAGE>

                                   /s/
                                   --------------------------------------------
                                            Name: Rodney D. Laney

                                   Address:

                                   Telecopier No.: (___) ___-_____

                                      S-2

         [MedSource Technologies, Inc. - Registration Rights Agreement
                         - Stockholder Signature Page]

<PAGE>

                                   /s/
                                   --------------------------------------------
                                            Name: John T. Riddle

                                   Address:

                                   1351 Highway 301
                                   Trenton, GA 30752
                                   Telecopier No.: (___) ___-____

                                      S-2

         [MedSource Technologies, Inc. - Registration Rights Agreement
                         - Stockholder Signature Page]

<PAGE>

                                   /s/
                                   --------------------------------------------
                                            Name: Ronald B. Roth

                                   Address:

                                   9 Northfield Road
                                   Signal Mountain, TN 37377
                                   Telecopier No.: (423) 886-6711

                                      S-2

         [MedSource Technologies, Inc. - Registration Rights Agreement
                         - Stockholder Signature Page]

<PAGE>

                                   /s/
                                   --------------------------------------------
                                            Name: Lane Keith

                                   Address:

                                   8011 Rosemere Way
                                   Chattanooga, TN 37421
                                   Telecopier No.: (423) 892-3019

                                      S-2

         [MedSource Technologies, Inc. - Registration Rights Agreement
                         - Stockholder Signature Page]

<PAGE>

                                   /s/
                                   --------------------------------------------
                                            Name: Lance Monroe

                                   Address:

                                   8903 Grey Mountain Drive
                                   Doltewah, TN 37363
                                   Telecopier No.: (423) 396-2817

                                      S-2

         [MedSource Technologies, Inc. - Registration Rights Agreement
                         - Stockholder Signature Page]

<PAGE>

                                   /s/
                                   --------------------------------------------
                                            Name: Rudolph E. Carlson

                                   Address:

                                   Telecopier No.: (___) ___-____

                                      S-2

         [MedSource Technologies, Inc. - Registration Rights Agreement
                         - Stockholder Signature Page]

<PAGE>

                                   /s/
                                   --------------------------------------------
                                            Name: Roy Johnson

                                   Address:

                                   14 Hobby Drive
                                   Ridgefield, CT 06877
                                   Telecopier No.: (203) 438-6667

                                      S-2

         [MedSource Technologies, Inc. - Registration Rights Agreement
                         - Stockholder Signature Page]

<PAGE>

                                   /s/
                                   --------------------------------------------
                                            Name: Gary Messangale

                                   Address:

                                   185 Slygo Road
                                   Trenton, GA 30752
                                   Telecopier No.: (706) 657-4602

                                      S-2

         [MedSource Technologies, Inc. - Registration Rights Agreement
                         - Stockholder Signature Page]

<PAGE>

                                   /s/
                                   --------------------------------------------
                                            Name: Shannon Prince

                                   Address:

                                   454 Creek Rd.
                                   Wildwood, GA 30757
                                   Telecopier No.: (706) 657-5157

                                      S-2

         [MedSource Technologies, Inc. - Registration Rights Agreement
                         - Stockholder Signature Page]

<PAGE>

                                   /s/
                                   --------------------------------------------
                                            Name: Brenda Neimand

                                   Address:

                                   777 15th Street
                                   Boulder, CO 80302
                                   Telecopier No.: (303) 448-9559

                                      S-2

         [MedSource Technologies, Inc. - Registration Rights Agreement
                         - Stockholder Signature Page]

<PAGE>

                                   THE GENEVA COMPANIES, INC.

                                   By:
                                      -----------------------------------------
                                            Name: David Troob
                                            Title: Chairman and CEO

                                   Address:

                                   Telecopier No.: (___) ___-____

                                      S-2

         [MedSource Technologies, Inc. - Registration Rights Agreement
                         - Stockholder Signature Page]<PAGE>

                                                                   EXHIBIT 10.11
                                                                   -------------

                                 1999 STOCK PLAN
                                       of
                          MEDSOURCE TECHNOLOGIES, INC.
               (As Amended and Restated Through December 14, 2001)

          1.  Purposes of the Plan. This stock plan (the "Plan") is intended to
              --------------------
provide an incentive to employees (including directors and officers who are
employees) and to consultants and directors who are not employees of MedSource
Technologies, Inc., a Delaware corporation (the "Company"), or any of its
Subsidiaries (as defined in paragraph 18), and to offer an additional inducement
in obtaining the services of such persons. The Plan provides for the grant of
"nonqualified stock options," which do not qualify as "incentive stock options"
within the meaning of Section 422 of the Internal Revenue Code of 1986, as
amended (the "Code"), and shares of stock of the Company that may be subject to
contingencies or restrictions (collectively with the options, "Awards").

          2.  Stock Subject to the Plan. Subject to the provisions of paragraph
              -------------------------
11, the aggregate number of shares of Common Stock (as defined in paragraph 18)
that may be granted under the Plan shall not exceed 4,430,000. Such shares of
Common Stock may, in the discretion of the Board of Directors of the Company
(the "Board of Directors"), consist either in whole or in part of authorized but
unissued shares of Common Stock or shares of Common Stock held in the treasury
of the Company. Subject to the provisions of paragraph 12, any shares of Common
Stock subject to an option that for any reason expires, is cancelled or is
terminated unexercised or that ceases for any reason to be exercisable or a
restricted stock Award that for any reason is forfeited, shall again become
available for the granting of Awards under the Plan. The Company shall at all
times during the term of the Plan reserve and keep available such number of
shares of Common Stock as will be sufficient to satisfy the requirements of the
Plan.

          3.  Administration of the Plan. The Plan shall be administered by the
              --------------------------
Board of Directors or a committee (the "Committee") of the Board of Directors.
Those administrating the Plan are referred to herein as the "Administrators." At
any time, and for so long as, the Common Stock is registered pursuant to section
12 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), the
Administrators shall not include any person that would prevent an Award from
being exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3
thereunder. Except as otherwise provided by the Board of Directors, the bylaws
of the Company or applicable law, a majority of the members of the Committee
shall constitute a quorum, and the acts of a majority of the members present at
any meeting at which a quorum is present, and any acts approved in writing by
all members without a meeting, shall be the acts of the Committee.

          Subject to the express provisions of the Plan, the Administrators
shall have the authority, in their sole discretion, to determine: who shall be
granted Awards; the type of Award to be granted, the times when an Award shall
be granted; the number of shares of Common Stock to be subject to each Award;
the term of each option; the date each option shall vest or become

<PAGE>

exercisable; whether an option shall vest or be exercisable in whole, in part or
in installments and, if in installments, the number of shares of Common Stock to
be subject to each installment; whether the installments shall be cumulative,
the date each installment shall become exercisable and the term of each
installment; whether shares of Common Stock may be issued upon the exercise of
an option as partly paid and, if so, the dates when future installments of the
price shall become due and the amounts of such installments; the exercise price
of an option and the price, if any, to be paid for a stock Award; the form of
payment of the exercise price; the restrictions, if any, imposed with respect to
a stock Award and whether and under what conditions to waive any such
restriction; whether to restrict the sale or other disposition of the shares of
Common Stock acquired upon the exercise of an option and, if so, whether and
under what conditions to waive any such restriction; whether and under what
conditions to subject all or a portion of the grant or exercise of an option,
the vesting of a stock Award or the shares acquired pursuant to the exercise of
an option to the fulfillment of certain restrictions or contingencies as
specified in the contract referred to in paragraph 10 hereof (the "Contract"),
including without limitation, restrictions or contingencies relating to entering
into a covenant not to compete with the Company, any of its Subsidiaries or a
Parent (as defined in paragraph 18), to financial objectives for the Company,
any of its Subsidiaries or a Parent, a division of any of the foregoing, a
product line or other category, and/or to the period of continued employment of
the Award holder with the Company, any of its Subsidiaries or a Parent, and to
maintain the confidentiality of information provided to, or learned by, the
Award holder, and to determine whether such restrictions or contingencies have
been met; whether to accelerate the date on which an option may vest or be
exercised or to waive any restriction or limitation with respect to any Award;
whether an Award holder is Disabled (as defined in paragraph 18); the amount, if
any, necessary to satisfy the obligation of the Company, a Subsidiary or Parent
to withhold taxes or other amounts with respect to the grant; the Fair Market
Value (as defined in paragraph 18) of a share of Common Stock; to construe the
respective Contracts and the Plan; with the consent of the Award holder, to
cancel or modify an Award, provided, that the modified provision is permitted to
                           --------
be included in an Award granted under the Plan on the date of the modification,
to prescribe, amend and rescind rules and regulations relating to the Plan; and
to make all other determinations necessary or advisable for administering the
Plan. Any controversy or claim arising out of or relating to the Plan, any Award
granted under the Plan or any Contract shall be determined unilaterally by the
Administrators in their sole discretion. The determinations of the
Administrators on the matters referred to in this paragraph 3 shall be
conclusive and binding on the parties. No member or former member of the
Administrators shall be liable for any action, failure to act or determination
made in good faith with respect to the Plan or Contract or Award hereunder.

          4.  Eligibility. The Administrators may from time to time, in their
              -----------
sole discretion, consistent with the purposes of the Plan, grant Awards to (a)
employees (including officers and directors who are employees) of the Company or
any of its Subsidiaries, (b) consultants to the Company or any of its
Subsidiaries and (c) non-employee directors of the Company. Such Awards granted
shall cover such number of shares of Common Stock as the Administrators may
determine, in their sole discretion, as set forth in the applicable Contract;
provided, however, if, on the date of grant, the Common Stock or any other class
--------  -------
of common

                                       -2-

<PAGE>

equity securities of the Company is required to be registered pursuant to
section 12 of the Exchange Act, the maximum number of shares subject to options
that may be granted to any employee during any calendar year under the Plan (the
"162(m) Maximum") shall be 100,000 shares.

          5.   Options.
               -------

          (a)  Grant. The Administrators may from time to time, in their sole
               -----
discretion, consistent with the purposes of the Plan, grant options to persons
eligible for such grant pursuant to paragraph 4.

          (b)  Exercise Price. The exercise price of the shares of Common Stock
               --------------
under each option shall be determined by the Administrators, in their sole
discretion, as set forth in the applicable Contract.

          (c)  Term. The term of each option granted pursuant to the Plan shall
               ----
be such term as is established by the Administrators, in their sole discretion,
as set forth in the applicable Contract. Options shall be subject to earlier
termination as hereinafter provided.

          (d)  Exercise. An option (or any part or installment thereof), to the
               --------
extent then vested and exercisable, shall be exercised (to the extent the holder
elects) by giving written notice to the Company at its principal office stating
which option is being exercised, specifying the number of shares of Common Stock
as to which such option is being exercised and accompanied by payment in full of
the aggregate exercise price therefor (or the amount due on exercise if the
applicable Contract permits installment payments) (a) in cash or by certified
check or (b) if the applicable Contract permits, with previously acquired shares
of Common Stock that are fully paid, vested, transferrable and have been held
for the requisite period to avoid a charge to the Company's earnings for
financial accounting purposes and that have an aggregate Fair Market Value on
the date of exercise equal to the aggregate exercise price of all options being
exercised, or with any combination of cash, certified check or shares of Common
Stock having such value. The Company shall not be required to issue any shares
of Common Stock pursuant to any such option until all required payments,
including any required withholding, have been made.

          A person entitled to receive Common Stock upon the exercise of an
option shall not have the rights of a stockholder with respect to such shares of
Common Stock until the date of issuance of a stock certificate for such shares
or in the case of uncertificated shares, an entry is made on the books of the
Company's transfer agent representing such shares; provided, however, that until
                                                   --------  -------
such stock certificate is issued or book entry is made, any optionee using
previously acquired shares of Common Stock in payment of an option exercise
price shall continue to have the rights of a stockholder with respect to such
previously acquired shares.

          6.   Restricted Stock. The Administrators, in their sole discretion,
               ----------------
may from time to time, consistent with the purposes of the Plan, grant shares of
Common Stock to persons

                                       -3-

<PAGE>

eligible for such grant pursuant to paragraph 4. The grant may require the Award
holder to pay such price per share therefor, if any, as the Administrators may
determine, in their sole discretion. Such shares may be subject to such
contingencies and restrictions as the Administrators may determine, as set forth
in the Contract. Upon the issuance of the stock certificate for a stock Award,
or in the case of uncertificated shares, the entry on the books of the Company's
transfer agent representing such shares, notwithstanding any contingencies or
restrictions to which the shares are subject, the Award holder shall be
considered to be the record owner of the shares, and subject to the
contingencies and restrictions set forth in the Award, shall have all rights of
a shareholder of record with respect to such shares, including the right to vote
and to receive distributions. Upon the occurrence of any such contingency or
restriction, the Award holder may be required to forfeit all or a portion of
such shares back to the Company. The shares shall vest in the Award holder when
all of the restrictions and contingencies lapse. Until such time, the
Administrators may require that such shares be held by the Company, together
with a stock power duly endorsed in blank by the Award holder.

          7.   Termination of Relationship. Except as may otherwise be expressly
               ---------------------------
provided in the applicable Contract, an optionee whose relationship with the
Company as a director, or with the Company or any of its Subsidiaries or a
Parent as an employee or a consultant, has terminated for any reason (other than
as a result of the death or Disability of the optionee) may exercise his
options, to the extent exercisable on the date of such termination, at any time
within three months after the date of termination, but not thereafter and in no
event after the date the option would otherwise have expired; provided, however,
                                                              --------  -------
that if such relationship is terminated either (a) for Cause (as defined in
paragraph 18), or (b) without the consent of the Company, such option shall
terminate immediately.

          For the purposes of the Plan, an employment relationship shall be
deemed to exist between an individual and the Company, any of its Subsidiaries
or a Parent if, at the time of the determination, the individual would be
treated as an employee of such entity for purposes of Section 422(a) of the Code
assuming such section applied. As a result, an individual on military, sick
leave or other bona fide leave of absence shall continue to be considered an
employee for purposes of the Plan during such leave if the period of the leave
does not exceed 90 days, or, if longer, so long as the individual's right to
reemployment with the Company, any of its Subsidiaries or a Parent is guaranteed
either by statute or by contract. If the period of leave exceeds 90 days and the
individual's right to reemployment is not guaranteed by statute or by contract,
the employment relationship shall be deemed to have terminated on the 91st day
of such leave.

          Except as may otherwise be expressly provided in the Contract, upon
the termination of the relationship of a holder of a stock Award as a director
of the Company, or as an employee of, or consultant to, the Company, or any of
its Subsidiaries or a Parent, for any reason (including his death or
Disability), such stock Award shall cease any further vesting and the unvested
portion of such Award as of the date of such termination shall be forfeited to
the Company for no consideration.

                                       -4-

<PAGE>

          Except as may otherwise be expressly provided in the applicable
Contract, Awards granted under the Plan to a director, employee or consultant
shall not be affected by any change in the status of the Award holder so long as
such Award holder continues to be a director of the Company, or an employee of,
or a consultant to, the Company or any of its Subsidiaries or a Parent
(regardless of having changed from one to the other or having been transferred
from one entity to another).

          Nothing in the Plan or in any option granted under the Plan shall
confer on any Award holder any right to continue in the employ of, or as a
consultant to, the Company, any of its Subsidiaries or a Parent, or as a
director of the Company, or interfere in any way with any right of the Company,
any of its Subsidiaries or a Parent to terminate the Award holder's relationship
at any time for any reason whatsoever without liability to the Company, any of
its Subsidiaries or a Parent.

          8.   Death or Disability of an Optionee. Except as may otherwise be
               ----------------------------------
expressly provided in the applicable Contract, if an optionee dies (a) while he
is a director of the Company, or an employee of, or consultant to, the Company,
any of its Subsidiaries or a Parent, (b) within three months after the
termination of such relationship (unless such termination was for Cause or
without the consent of the Company) or (c) within one year following the
termination of such relationship by reason of his Disability, the options that
were granted to him as a director, employee or consultant may be exercised, to
the extent exercisable on the date of his death, by the personal representative
of his estate at any time within one year after death, but not thereafter and in
no event after the date the option would otherwise have expired.

          Except as may otherwise be expressly provided in the applicable
Contract, any optionee whose relationship as a director of the Company, or an
employee of, or consultant to, the Company, its Parent and Subsidiaries has
terminated by reason of such optionee's Disability may exercise the options that
were granted to him as a director, employee or consultant, to the extent
exercisable upon the effective date of such termination, at any time within one
year after such date (except as provided in clause (c) of the preceding
paragraph), but not thereafter and in no event after the date the option would
otherwise have expired.

          9.   Compliance with Securities Laws. Notwithstanding anything herein
               -------------------------------
to the contrary, the Administrators may require, in their sole discretion, as a
condition to the receipt of any Award or the exercise of any option that either
(a) a Registration Statement under the Securities Act of 1933, as amended (the
"Securities Act"), with respect to the shares of Common Stock to be issued upon
such receipt or exercise shall be effective and current at the time of exercise,
or (b) there is an exemption from registration under the Securities Act for the
issuance of the shares of Common Stock upon such receipt or exercise. Nothing
herein shall be construed as requiring the Company to register shares subject to
any Award under the Securities Act or to keep any Registration Statement
effective or current.

          The Administrators may require, in their sole discretion, as a
condition to the receipt of an Award or the exercise of any option that the
Award holder execute and deliver to

                                       -5-

<PAGE>

the Company his representations and warranties, in form, substance and scope
satisfactory to the Administrators, which the Administrators determine are
necessary or convenient to facilitate the perfection of an exemption from the
registration requirements of the Securities Act, applicable state securities
laws or other legal requirement, including without limitation that (a) the
shares of Common Stock to be issued upon the receipt of the Award or the
exercise of the option are being acquired by the Award holder for his own
account, for investment only and not with a view to the resale or distribution
thereof, and (b) any subsequent resale or distribution of shares of Common Stock
by such Award holder will be made only pursuant to (i) a Registration Statement
under the Securities Act which is effective and current with respect to the
shares of Common Stock being sold, or (ii) a specific exemption from the
registration requirements of the Securities Act, but in claiming such exemption,
the Award holder shall, prior to any offer of sale or sale of such shares of
Common Stock, provide the Company with a favorable written opinion of counsel
satisfactory to the Company, in form, substance and scope satisfactory to the
Company, as to the applicability of such exemption to the proposed sale or
distribution.

          In addition, if at any time the Administrators shall determine, in
their sole discretion, that the listing or qualification of the shares of Common
Stock subject to any Award on any securities exchange, Nasdaq or under any
applicable law or self-regulating agency rule, or the consent or approval of any
governmental agency or regulatory body, is necessary or desirable as a condition
to, or in connection with, the granting of an Award or the issuing of shares of
Common Stock upon exercise of an option, such Award may not be granted and such
option may not be exercised in whole or in part unless such listing,
qualification, consent or approval shall have been effected or obtained free of
any conditions not acceptable to the Administrators.

          10.  Contracts. Each Award shall be evidenced by an appropriate
               ---------
Contract which shall be duly executed by the Company and the Award holder, and
shall contain such terms, provisions and conditions not inconsistent herewith as
may be determined by the Administrators. The terms of each Award and Contract
need not be identical.

          11.  Adjustments Upon Changes in Common Stock.
               ----------------------------------------

          (a)  Notwithstanding any other provision of the Plan, in the event of
a stock dividend, stock split, combination, recapitalization, merger or
consolidation in which the Company is the surviving corporation, spin-off,
split-up, combination or exchange of shares or the like which results in a
change in the number or kind of shares of Common Stock which is outstanding
immediately prior to such event, the aggregate number and kind of shares subject
to the Plan, the aggregate number and kind of shares subject to each outstanding
option and the exercise price thereof, and the 162(m) Maximum shall be
appropriately adjusted by the Board of Directors to convert the unexercised
portion of the option into an option to acquire such number and kind of shares
or other consideration that the optionee would have been entitled to receive if
he had owned the shares underlying such portion of the option prior to such
event, and to apportion the remaining aggregate exercise price of the option
among such consideration to be received upon exercise. In making such
adjustments, the Board of Directors may provide for the elimination of
fractional shares which might otherwise be subject to options without payment

                                       -6-

<PAGE>

therefor. The determination of the Board of Directors with respect to any matter
under this subparagraph (a) shall be conclusive and binding on all parties
thereto.

          (b)  Notwithstanding any other provision of the Plan, in the event of
(i) the liquidation or dissolution of the Company, or (ii) a transaction (or
series of related transactions), other than the initial public offering of
Common Stock, that is approved by a majority of those who were members of the
Board of Directors prior to the first of such transaction or series (including,
without limitation, a merger, consolidation, sale of stock by the Company or its
stockholders, tender offer or sale of assets) and in which either (A) the voting
power (in the election of directors generally) of the Company's voting
securities outstanding immediately prior to such transaction(s) cease to
represent at least 50% of the combined voting power (in the election of
directors generally) of the Company or such surviving entity outstanding
immediately after such transaction(s), (B) all or substantially all of the
Company's assets are sold to an unaffiliated third party, or (C) the
registration of the Common Stock under the Exchange Act is terminated (if such
registration was in effect immediately prior to such transaction(s)), then,
unless otherwise provided in the applicable Contract or other provision is made
therefor in such transaction, (x) the Company (or its designee) may, at its
option purchase, and the holder shall sell, the vested portion of each option,
for an amount equal to the excess, if any, of the aggregate amount that would
have been received in the transaction by the optionee with respect to the shares
of Common Stock subject to the vested portion of such option, determined as if
he had exercised such vested portion immediately prior to the transaction, over
the aggregate exercise price therefor, which excess may be paid in cash or the
property to be received by owners of Common Stock in the transaction, and (y)
the unvested portion of each Award shall be cancelled without further action
and, in the case of a stock Award, the Company shall return to the Award holder
an amount equal to the lesser of (1) the consideration that would have been
received in the transaction by the Award holder with respect to such unvested
shares determined as if the such unvested portion had vested immediately prior
to the transaction or (2) the consideration, if any, paid by the Award holder to
the Company for such unvested shares.

          12.  Amendments and Termination of the Plan. The Plan was adopted by
               --------------------------------------
the Board of Directors on March 4, 1999. The Board of Directors, without further
approval of the Company's stockholders, may at any time suspend or terminate the
Plan, in whole or in part, or amend it from time to time in such respects as it
may deem advisable, including, without limitation, to comply with the provisions
of Rule 16b-3, Section 162(m) of the Code or any change in applicable law,
regulations, rulings or interpretations of administrative agencies; provided,
                                                                    --------
however, that no amendment shall be effective without the requisite prior or
-------
subsequent stockholder approval which would (a) except as contemplated in
paragraph 11, increase the maximum number of shares of Common Stock for which
Awards may be granted under the Plan or the 162(m) Maximum, (b) change the
eligibility requirements to receive Awards hereunder or (c) make any other
change for which applicable law requires stockholder approval. No termination,
suspension or amendment of the Plan shall, without the consent of the Award
holder, adversely affect his rights under any Award granted under the Plan. The
power of the Administrators to construe and administer any Award granted under
the Plan prior to the

                                       -7-

<PAGE>

termination or suspension of the Plan nevertheless shall continue after such
termination or during such suspension.

          13.  Transferability. Except as may otherwise be expressly provided in
               ---------------
the Contract, no option granted under the Plan shall be transferable and options
may be exercised (a) during the lifetime of the optionee, only by the optionee
and (b) after the death of the optionee, only by the personal representative of
his estate. Except as may otherwise be expressly provided in the Contract, a
stock Award, to the extent not vested, shall not be transferable. Except to the
extent provided above, Awards may not be assigned, transferred, pledged,
hypothecated or disposed of in any way (whether by operation of law or
otherwise) and shall not be subject to execution, attachment or similar process,
and any such attempted assignment, transfer, pledge, hypothecation or
disposition shall be null and void ab initio and of no force or effect.
                                   -- ------

          14.  Withholding Taxes. The Company, a Subsidiary or Parent may
               -----------------
withhold (a) cash, (b) shares of Common Stock to be issued under a stock Award
or upon exercise of an option having an aggregate Fair Market Value on the
relevant date, or (c) any combination thereof, in an amount equal to the amount
which the Administrators determine is necessary to satisfy the obligation of the
Company, a Subsidiary or Parent to withhold Federal, state and local income
taxes or other amounts incurred by reason of the grant, vesting, exercise or
disposition of an Award, or the disposition of the underlying shares of Common
Stock. Alternatively, the Company may require the holder to pay to the Company
such amount, in cash, promptly upon demand.

          15.  Legends; Payment of Expenses. The Company may endorse such legend
               ----------------------------
or legends upon the certificates for shares of Common Stock issued under a stock
Award or upon exercise of an option under the Plan and may issue such "stop
transfer" instructions to its transfer agent in respect of such shares as it
determines, in its discretion, to be necessary or appropriate to (a) prevent a
violation of, or to perfect an exemption from, the registration requirements of
the Securities Act or any applicable state securities laws, or (b) implement the
provisions of the Plan or any agreement between the Company and the Award holder
with respect to such shares of Common Stock.

          The Company shall pay all issuance taxes with respect to the issuance
of shares of Common Stock under a stock Award or upon the exercise of an option
granted under the Plan, as well as all fees and expenses incurred by the Company
in connection with such issuance.

          16.  Use of Proceeds. The cash proceeds received upon the exercise of
               ---------------
an option or grant of a stock Award under the Plan shall be added to the general
funds of the Company and used for such corporate purposes as the Board of
Directors may determine.

          17.  Substitutions and Assumptions of Options of Certain Constituent
               ---------------------------------------------------------------
Corporations. Anything in this Plan to the contrary notwithstanding, the Board
------------
of Directors may, without further approval by the stockholders, substitute new
Awards for prior options or

                                       -8-

<PAGE>

restricted stock of a Constituent Corporation (as defined in paragraph 18) or
assume the prior options of such Constituent Corporation.

          18.  Definitions. For purposes of the Plan, the following terms shall
               -----------
be defined as set forth below:

          (a)  "Cause" shall mean (i) in the case of an employee or consultant,
if there is a written employment or consulting agreement between the Award
holder and the Company, any of its Subsidiaries or a Parent which defines
termination of such relationship for cause, cause as defined in such agreement,
(ii) if there is no such agreement, cause as defined in the Contract, or (iii)
in the absence of both of the foregoing, (A) the commission of fraud or
embezzlement on the part of the Award holder, (B) the conviction of such Award
holder of, or the pleading by such Award holder of guilty or no contest to, (x)
any felony or (y) any crime involving moral turpitude, or (C) a material failure
by such Award holder to discharge his duties, responsibilities and obligations
to the Company, any of its Subsidiaries or a Parent that is not promptly cured
after notice thereof from the Company.

          (b)  "Common Stock" shall mean the common stock, par value $.01 per
share, of the Company, or such other class of stock of the Company into which
such stock is converted in a transaction or series of transactions described in
paragraph 11(a).

          (c)  "Constituent Corporation" shall mean any corporation which
engages with the Company, any of its Subsidiaries or a Parent in a transaction
described in Section 424(a) of the Code, or any Parent or any Subsidiary of such
corporation.

          (d)  "Disability" shall mean a permanent and total disability within
the meaning of Section 22(e)(3) of the Code.

          (e)  "Fair Market Value" of a share of Common Stock on any day shall
mean (i) if the principal market for the Common Stock is a national securities
exchange, the average of the highest and lowest sales prices per share of Common
Stock on such day as reported by such exchange or on a composite tape reflecting
transactions on such exchange, (ii) if the principal market for the Common Stock
is not a national securities exchange and the Common Stock is quoted on The
Nasdaq Stock Market ("Nasdaq"), and (A) if actual sales price information is
available with respect to the Common Stock, the average of the highest and
lowest sales prices per share of Common Stock on such day on Nasdaq, or (B) if
such information is not available, the average of the highest bid and lowest
asked prices per share of Common Stock on such day on Nasdaq, or (iii) if the
principal market for the Common Stock is not a national securities exchange and
the Common Stock is not quoted on Nasdaq, the average of the highest bid and
lowest asked prices per share of Common Stock on such day as reported on the OTC
Bulletin Board Service or by National Quotation Bureau, Incorporated or a
comparable service; provided, however, that if clauses (i), (ii) and (iii) of
                    --------  -------
this paragraph are all inapplicable, or if no trades have been made or no quotes
are available for such day, the fair market value of the Common Stock

                                       -9-

<PAGE>

shall be determined by the Board of Directors by any method consistent with
applicable regulations adopted by the Treasury Department relating to stock
options.

          (f)  "Parent" shall mean a "parent corporation" within the meaning of
Section 424(e) of the Code.

          (g)  "Subsidiary" shall mean a "subsidiary corporation" within the
meaning of Section 424(f) of the Code, or an unincorporated entity (including
without limitation a limited liability company) in which the Company owns
directly or indirectly through other Subsidiaries at least 50% of the capital or
profits interests in the entity.

          19.  Governing Law; Construction. The Plan, the Awards and Contracts
               ---------------------------
hereunder and all related matters shall be governed by, and construed in
accordance with, the laws of the State of Delaware, without regard to conflict
of law provisions that would defer to the substantive laws of another
jurisdiction.

          Neither the Plan nor any Contract shall be construed or interpreted
with any presumption against the Company by reason of the Company causing the
Plan or Contract to be drafted. Whenever from the context it appears
appropriate, any term stated in either the singular or plural shall include the
singular and plural, and any term stated in the masculine, feminine or neuter
gender shall include the masculine, feminine and neuter.

          20.  Partial Invalidity. The invalidity, illegality or
               ------------------
unenforceability of any provision in the Plan, any Award or Contract shall not
affect the validity, legality or enforceability of any other provision, all of
which shall be valid, legal and enforceable to the fullest extent permitted by
applicable law.

                                       -10-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00033-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00033-of-00352.parquet"}]]